secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spectral AI, Inc. (MDAI)
CIK:        0001833498
Form:       8-K
Filed at:   2026-05-26T20:00:52+00:00
Accession:  0001213900-26-061008
Event type: regulatory
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spectral AI receives FDA De Novo clearance for DeepView System for burn indication
--------------------------------------------------------------------------------

- FDA granted De Novo Classification for DeepView System, authorizing commercial distribution in the US.
- DeepView is a non-invasive, multispectral imaging device with proprietary AI algorithm to assess burn wound healing.
- System provides clinical assessment in ~20-25 seconds, trained on over 340 billion pixels of burn wound image data.
- CEO Vincent Capone calls it a 'defining moment' and 'watershed moment' in the company's history.
- Development supported in part by BARDA federal contract 75A50123C00049.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1833498/000121390026061008/0001213900-26-061008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1833498/000121390026061008/ea0292182-8k_spectral.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-061008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer